These RSV Vaccines Are Approved for Certain People

Preventing RSV in Infants Also Reduced Antibiotic Prescribing Across 32 Philadelphia Area Pediatric Primary Care Practices

Infants who received the RSV antibody nirsevimab got fewer antibiotics for respiratory infections, a study of 15,341 babies found.

Maternal RSV vaccine reduces infant RSV-associated hospitalizations by 80% through six months of life

Australia's RSV Maternal and Infant Protection Program is delivering strong protection for babies, with new research from The Kids Research Institute Australia showing RSV vaccination given during pregnancy reduces the risk of RSV-related hospitalization by more than 80% during an infant's first six months of life.

These RSV Vaccines Are Approved for Certain People

RSV Antibody Treatment for Infants and Babies In 2023, the FDA approved the monoclonal antibody treatment nirsevimab (Beyfortus) from Sanofi and AstraZeneca to prevent RSV infection in newborns, infants, and children up to 24 months old.e60dc2a1-f33c-4a05-9b50-8e3e8e597629e0e9997f-4847-4fbe-a652-4666516b70a2 Specifically, it’s approved for babies born during or entering their first RSV season and toddlers who are at risk for severe infection. Ho…